Rubén Cabanillas,Marta Diñeiro,Guadalupe A. Cifuentes,David Castillo,Patricia C. Pruneda,Rebeca Álvarez,Noelia Sánchez-Durán,Raquel Capín,Ana Plasencia,Mónica Viejo-Díaz,Noelia García-González,Inés Hernando,José L. Llorente,Alfredo Repáraz-Andrade,Cristina Torreira-Banzas,Jordi Rosell,Nancy Govea,Justo Ramón Gómez-Martínez,Faustino Núñez-Batalla,José A. Garrote,Ángel Mazón-Gutiérrez,María Costales,María Isidoro-García,Belén García-Berrocal,Gonzalo R. Ordóñez,Juan Cadiñanos

Abstract:BackgroundSensorineural hearing loss (SNHL) is the most common sensory impairment. Comprehensive next-generation sequencing (NGS) has become the standard for the etiological diagnosis of early-onset SNHL. However, accurate selection of target genomic regions (gene panel/exome/genome), analytical performance and variant interpretation remain relevant difficulties for its clinical implementation.MethodsWe developed a novel NGS panel with 199 genes associated with non-syndromic and/or syndromic SNHL. We evaluated the analytical sensitivity and specificity of the panel on 1624 known single nucleotide variants (SNVs) and indels on a mixture of genomic DNA from 10 previously characterized lymphoblastoid cell lines, and analyzed 50 Spanish patients with presumed hereditary SNHL not caused by GJB2/GJB6, OTOF nor MT-RNR1 mutations.ResultsThe analytical sensitivity of the test to detect SNVs and indels on the DNA mixture from the cell lines was > 99.5%, with a specificity > 99.9%. The diagnostic yield on the SNHL patients was 42% (21/50): 47.6% (10/21) with autosomal recessive inheritance pattern (BSND, CDH23, MYO15A, STRC [n = 2], USH2A [n = 3], RDX, SLC26A4); 38.1% (8/21) autosomal dominant (ACTG1 [n = 3; 2 de novo], CHD7, GATA3 [de novo], MITF, P2RX2, SOX10), and 14.3% (3/21) X-linked (COL4A5 [de novo], POU3F4, PRPS1). 46.9% of causative variants (15/32) were not in the databases. 28.6% of genetically diagnosed cases (6/21) had previously undetected syndromes (Barakat, Usher type 2A [n = 3] and Waardenburg [n = 2]). 19% of genetic diagnoses (4/21) were attributable to large deletions/duplications (STRC deletion [n = 2]; partial CDH23 duplication; RDX exon 2 deletion).ConclusionsIn the era of precision medicine, obtaining an etiologic diagnosis of SNHL is imperative. Here, we contribute to show that, with the right methodology, NGS can be transferred to the clinical practice, boosting the yield of SNHL genetic diagnosis to 50–60% (including GJB2/GJB6 alterations), improving diagnostic/prognostic accuracy, refining genetic and reproductive counseling and revealing clinically relevant undiagnosed syndromes.

Rethinking non-syndromic hearing loss and its mimics in the genomic era

Non-Syndromic Hearing Loss and High-Throughput Strategies to Decipher Its Genetic Heterogeneity

Genome and base editing for genetic hearing loss

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human mutations

A Large Scale Hearing Loss Screen Reveals an Extensive Unexplored Genetic Landscape for Auditory Dysfunction

DNA Diagnostics of Hereditary Hearing Loss: A Targeted Resequencing Approach Combined with a Mutation Classification System

Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients

Genetic Hearing Loss and Gene Therapy

Pathological mechanisms and candidate therapeutic approaches in the hearing loss of mice carrying human MIR96 mutations

The applications of CRISPR/Cas-mediated genome editing in genetic hearing loss

Genotype phenotype correlations for hearing impairment: Approaches to management

Contiguous Gene Syndromes and Hearing Loss: A Clinical Report of Xq21 Deletion and Comprehensive Literature Review

Gene Therapy for Inherited Hearing Loss: Updates and Remaining Challenges

Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations.

Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach

Mutational spectrum in patients with dominant non-syndromic hearing loss in Austria

Recent advances and future challenges in gene therapy for hearing loss

Etiologic Diagnosis of Genetic Hearing Loss in an Ethnically Diverse Deafness Cohort

Deafness: from genetic architecture to gene therapy

Recent advances in genetic etiology of non-syndromic deafness in children